Morning Briefing - 500 Beiträge pro Seite
eröffnet am 19.03.07 13:29:20 von
neuester Beitrag 19.03.07 18:57:43 von
neuester Beitrag 19.03.07 18:57:43 von
Beiträge: 3
ID: 1.119.460
ID: 1.119.460
Aufrufe heute: 0
Gesamt: 883
Gesamt: 883
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 32 Minuten | 2188 | |
vor 1 Stunde | 1559 | |
vor 1 Stunde | 1521 | |
vor 1 Stunde | 1305 | |
vor 1 Stunde | 738 | |
vor 34 Minuten | 601 | |
gestern 23:30 | 500 | |
gestern 23:07 | 455 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.800,34 | +0,43 | 218 | |||
2. | 3. | 0,2290 | +9,05 | 113 | |||
3. | 2. | 0,3900 | +25,81 | 92 | |||
4. | 4. | 161,32 | +0,72 | 65 | |||
5. | 5. | 2,5645 | -0,04 | 58 | |||
6. | 7. | 6,7980 | +2,35 | 40 | |||
7. | 6. | 0,1656 | -0,30 | 39 | |||
8. | 10. | 2.368,11 | +0,93 | 36 |
CEPH Cepheid's Xpert(TM) EV Test for Enteroviral Meningitis, Run on the GeneXpert Platform, Receives FDA Clearance
RSH RadioShack cut at Morgan Stanley, top-line worries
BEAS BEA Systems upped at UBS, rebound seen in longer term
QCOM Nokia files claims against Qualcomm in Europe
AGIX AstraZeneca: AtheroGenics says trial didn't meet endpoint
AGIX AtheroGenics says AGI-1067, did not show a difference from placebo in its composite primary endpoint
AGIX London-based drugmaker AstraZeneca Plc had agreed to pay AtheroGenics up to $1 billion for exclusive rights to the drug
NCT Newcastle Investment (NCT) agreed to buy a $1.7 billion portfolio of 7,300 subprime residential mortgage loans
ABN ABN Amro shares rally on deal talk; Barclays to comment soon, Barclays to make statement on ABN Amro before Tuesday's open
SIGA The 2-year-old son of a soldier deployed to Iraq is in critical condition after developing a reaction to his father's smallpox vaccination, the U.S. Centers for Disease Control and Prevention said on Saturday
MarketWatch "Will U.S. finish preparing for flu pandemic before clock runs out" (SNY, CBMX,...)
└ SNY has a vaccine
└ CBMX has a air force contract for detectors
Viel Erfolg
RSH RadioShack cut at Morgan Stanley, top-line worries
BEAS BEA Systems upped at UBS, rebound seen in longer term
QCOM Nokia files claims against Qualcomm in Europe
AGIX AstraZeneca: AtheroGenics says trial didn't meet endpoint
AGIX AtheroGenics says AGI-1067, did not show a difference from placebo in its composite primary endpoint
AGIX London-based drugmaker AstraZeneca Plc had agreed to pay AtheroGenics up to $1 billion for exclusive rights to the drug
NCT Newcastle Investment (NCT) agreed to buy a $1.7 billion portfolio of 7,300 subprime residential mortgage loans
ABN ABN Amro shares rally on deal talk; Barclays to comment soon, Barclays to make statement on ABN Amro before Tuesday's open
SIGA The 2-year-old son of a soldier deployed to Iraq is in critical condition after developing a reaction to his father's smallpox vaccination, the U.S. Centers for Disease Control and Prevention said on Saturday
MarketWatch "Will U.S. finish preparing for flu pandemic before clock runs out" (SNY, CBMX,...)
└ SNY has a vaccine
└ CBMX has a air force contract for detectors
Viel Erfolg
Antwort auf Beitrag Nr.: 28.369.922 von GoofMan am 19.03.07 13:29:20LEND Accredited Home Lenders receives notice of delisting; in discussions regarding a possible financing arrangement with a third party
EAGL EGL, Inc. Enters Into Agreement to Sell to Investor Group for $38.00 Per Share
EAGL EGL, Inc. Enters Into Agreement to Sell to Investor Group for $38.00 Per Share
Aktueller Stand der berichteten Aktien:
Shorts
AGIX -61%
LEND -12%
QCOM -1%
Longs:
SIGA +18%
EAGL +5%
NCT +2%
Hoffe ihr habt gut verdient heute. Gute Nacht
Shorts
AGIX -61%
LEND -12%
QCOM -1%
Longs:
SIGA +18%
EAGL +5%
NCT +2%
Hoffe ihr habt gut verdient heute. Gute Nacht
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
214 | ||
112 | ||
96 | ||
75 | ||
56 | ||
40 | ||
39 | ||
37 | ||
34 | ||
30 |